SCHEMBL7941798

SCHEMBL7941798

O=c1c2c[nH]c3ccccc3n-2c(=O)n1-c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PGR P06401 4/20 0.46
MPI P34949 1/20 0.44
PDE7A Q13946 1/20 0.42
PDE7B Q9NP56 1/20 0.42
MAPK1 P28482 1/20 0.41
MAPK8 P45983 2/20 0.40
MAPK9 P45984 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
KDM4E B2RXH2 1/20 0.39
ATM Q13315 1/20 0.39
KMT2A Q03164 3/20 0.38
GSK3A P49840 2/20 0.38
GSK3B P49841 2/20 0.38
GAA P10253 1/20 0.38
MEN1 O00255 1/20 0.37
LMNA P02545 1/20 0.37
TSHR P16473 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7941792 0.88 SMN1; SMN2 (0.43) PGRMAPK1KDM4EKMT2ALMNA
SCHEMBL7951665 0.88 LMNA (0.40) PGRMPIMAPK1MAPK8MAPK9
SCHEMBL7941785 0.88 LMNA (0.39) PGRMPIL3MBTL1KMT2ALMNA
SCHEMBL7949731 0.88 HSP90AA1 (0.41) PGRPDE7APDE7BMAPK1L3MBTL1
SCHEMBL7949177 0.86 KDM4E (0.51) MPIL3MBTL1KDM4EKMT2AGAA
SCHEMBL7953532 0.85 MAPT (0.51) MAPK1ATMKMT2AMEN1LMNA
SCHEMBL7951689 0.85 POLB (0.46) PGRMAPK1MAPK8GAA
SCHEMBL7949708 0.85 MAPT (0.47) MPIL3MBTL1KDM4EKMT2AMEN1
SCHEMBL7941781 0.85 ADORA3 (0.43) MPIKDM4EGAALMNA
SCHEMBL7947997 0.83 PGR (0.32) PGRMPIL3MBTL1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6268496-B1 GAMMA-AMINOBUTYRIC ACID RECEPTOR LIGANDS NEUROGEN CORPORATION 2001-07-31 US claimed
EP-0555391-B1 CERTAIN IMIDAZOQUINOXALINES; A NEW CLASS OF GABA BRAIN RECEPTOR LIGANDS NEUROGEN CORP (US) 2000-07-12 EP claimed
EP-0555391-A1 CERTAIN IMIDAZOQUINOXALINES; A NEW CLASS OF GABA BRAIN RECEPTOR LIGANDS NEUROGEN CORPORATION (US) 1993-08-18 EP claimed
US-5130430-A Anxiety, sleep disorders or seizures NEUROGEN CORPORATION (US) 1992-07-14 US claimed
WO-1992007853-A1 CERTAIN IMIDAZOQUINOXALINES; A NEW CLASS OF GABA BRAIN RECEPTOR LIGANDS NEUROGEN CORPORATION (US) 1992-05-14 WO claimed
US-6268496-B1 GAMMA-AMINOBUTYRIC ACID RECEPTOR LIGANDS NEUROGEN CORPORATION 2001-07-31 US disclosed
EP-0555391-B1 CERTAIN IMIDAZOQUINOXALINES; A NEW CLASS OF GABA BRAIN RECEPTOR LIGANDS NEUROGEN CORP (US) 2000-07-12 EP disclosed
EP-0555391-A1 CERTAIN IMIDAZOQUINOXALINES; A NEW CLASS OF GABA BRAIN RECEPTOR LIGANDS NEUROGEN CORPORATION (US) 1993-08-18 EP disclosed
US-5130430-A Anxiety, sleep disorders or seizures NEUROGEN CORPORATION (US) 1992-07-14 US disclosed
WO-1992007853-A1 CERTAIN IMIDAZOQUINOXALINES; A NEW CLASS OF GABA BRAIN RECEPTOR LIGANDS NEUROGEN CORPORATION (US) 1992-05-14 WO disclosed